Sponsored Links

Pull Up (Nasdaq: SMTK) Before The Bell Rings With 560% Revenue Growth And Less Than 20M Shares In Its Public Float



Any content you receive is for information purposes only. Always conduct your own research.

*Sponsored

Market Crux Just Put Smartkem Inc (NASDAQ: SMTK) At The Top Of This Morning’s Watchlist—Monday, August 3, 2026

Don’t Miss Our Next Update—Get Real-Time Alerts Sent Directly To Your Phone. Up To 10X Faster Than Email.

Check Out SMTK While It’s Still Early…

August 3, 2026

Dear Reader,

Minutes before the bell, Smartkem, Inc. (NASDAQ: SMTK) sits at the center of two stories happening at the same time.

The first is a semiconductor materials story. SMTK's proprietary TRUFLEX inks print transistors on plastic at room temperature while traditional fabs cost $20B and take years to build.

The company has signed a paid proof-of-concept agreement with a global consumer electronics leader for MicroLED wearables and advanced a joint development agreement with Manz Asia for AI chip packaging.

Revenue is up 560% year over year with 61% gross margins, and the addressable markets are substantial — organic semiconductors are projected to reach $63.76B by 2030 and flexible electronics are forecast to approach $96.77B by 2033. SMTK has captured only a fraction of a percent of either.

The second is a critical minerals story. SMTK has deployed $9.3M in convertible bridge loans into Ferrox Critical Minerals and holds board-level exclusivity over all major Ferrox transactions through year-end.

Three days ago, the federal government invoked the Defense Production Act on recoverable critical minerals. Meanwhile, institutions have committed roughly $7M across multiple closings since March into a company valued near $5M, and the public float sits at approximately 19.43M shares.

The bell rings in minutes. See full story here.

Inline Image

On July 16, 2026, Smartkem amended its Securities Purchase Agreement to add new institutional holders and expand the facility to approximately $17.1M in total authorized capacity — a signal of conviction at these valuations. Roughly $7M has already been deployed across multiple closings since March.

Think about what that ratio means. Institutions have already put in roughly $7M — which is more than the company's current market cap around $5M. That's not a rounding error. And SMTK did it across multiple closings over four months, which means each tranche was a separate decision. Nobody was locked in.

They could have stopped after the first closing and walked.

The timing aligns with another major strategic move.

Between March and July 2026, Smartkem deployed $9.3M in convertible bridge loans to Ferrox Critical Minerals, securing board-level decision-making power over all major Ferrox transactions through December 31, 2026.

These aren't incremental moves. They signal SMTK is positioning itself at the intersection of two high-priority infrastructure trends: semiconductor innovation and critical materials supply chain security.

On the revenue side, Smartkem posted an approximate 560% YoY revenue increase.

Gross margins held at approximately 61%. The company is still pre-scale, but the trajectory changed direction in a material way.

Market demand exists to support this positioning.

Organic semiconductors are expected to reach approximately $63.76B by 2030, at approximately 13.3% annual growth. Flexible electronics are set to expand from approximately $43.23B in 2026 to approximately $96.77B by 2033 at 12.2% annual growth.

Flexible OLED displays alone grow at approximately 24.2% annually, reaching approximately $54.51B by 2030.

SMTK currently has approximately 19.43M shares listed as available to the public against roughly 25.8M shares outstanding.

A float that tight may have the potential to generate big swings if demand shifts.

About Smartkem, Inc.

Inline Image

Smartkem develops and manufactures custom electronic materials designed to enable the next generation of electronics.

Our advanced TRUFLEX® materials integrate into existing manufacturing processes, supporting efficient, scalable production and high-performance outcomes across a broad range of electronic applications.

We combine materials science expertise with practical engineering to deliver tailored solutions for partners seeking to innovate in electronics.

Inline Image

The Case For Watching SMTK Right Now

Building an Equity Stake in Critical Minerals Through Ferrox

Over four months (April-July 2026), Smartkem deployed $9.3M across three convertible bridge loans to Ferrox Critical Minerals (April 23: $2.3M loan; June 22: $2.7M loan; July 27: $4.9M loan).

This isn't just capital raising—it's strategic positioning. Each loan converts into Ferrox shares at either fair market value or an $80M equity valuation, with Smartkem collecting $800K in origination fees.

More importantly, Smartkem holds restrictive covenants, rights of first refusal, and exclusivity over all major Ferrox corporate transactions through December 31, 2026.

This means Smartkem isn't a passive lender—it's a board-level participant in Ferrox's strategic decisions.

This is worth taking note of because Ferrox controls rare earth and critical minerals supply chains.

Those inputs are essential for advanced semiconductor manufacturing, battery production, and national defense applications. By securing equity conversion rights and decision-making power at Ferrox, Smartkem is positioning itself at the intersection of two infrastructure trends: semiconductor innovation and critical materials security.

If Ferrox succeeds in securing domestic supply contracts (which is plausible given current national security priorities), Smartkem's equity upside potential could be substantial.

$7M Institutional Capital in 90 Days Signals Conviction

Between March 30 and July 24, 2026, Smartkem closed $7M from multiple institutional Series A private placements, including closings on June 22 ($4M) and July 16 ($1M), plus additional tranches. Warrant issuances exceeded 43M shares.

Repeat institution-level position-building at such a small market cap doesn't happen by accident. It signals these firms see asymmetric risk-reward at current valuations.

560% Revenue Growth Changes the Trajectory

Smartkem posted roughly a 560% increase in TTM revenue. Gross margins held at 61%.

Revenue was near zero for years. Now it's climbing—driven by paid POC agreements, prototype services, and initial TRUFLEX ink sales. The trajectory shift from R&D burn to commercial traction is what institutions appear to be factoring in.

7 Reasons Why SMTK Is Topping Our Watchlist This Morning—Monday, August 3, 2026…

1. Low Float: With approximately 19.43M shares listed as available to the public, SMTK’s small float could witness the potential for big swings if demand begins to change.

2. Large Market Potential: Organic semiconductors forecasted to reach $63.76B by 2030; flexible electronics to hit $96.77B by 2033; IoT up to $4T by 2032. SMTK has only captured a fraction of a percent of those total addressable markets. Conventional valuation mechanics might suggest significant room for multiple expansion.

3. Rapid Revenue Growth: Smartkem's TTM revenue has increased 560% over the past year, with 61% gross margins.

4. Ferrox Critical Minerals Equity Stake: In 90 days (April-July 2026), Smartkem deployed $9.3M in convertible bridge loans to Ferrox Critical Minerals with board-level decision-making power through 2026. SMTK isn't just raising capital, it's positioning itself at the intersection of semiconductor innovation and national critical materials supply chain security.

5. Institutional Capital Signals Conviction: Between March 30 and July 24, 2026, Smartkem closed $7M from repeat institutional Series A holders at a $4.46M market cap. Sophisticated market participants generally don't deploy capital repeatedly at these valuations without seeing asymmetric risk-reward.

6. Cross-Sector Interest: A healthcare-focused entity acquired exactly 4.99% of SmartKem in June 2026 through a shelf takedown combined with convertible preferred securities — a non-semiconductor operator positioning just below the 5% reporting threshold in an advanced materials company suggests SMTK's biosensor and flexible medical electronics applications are drawing attention from outside the traditional semiconductor space.

7. Potential Defense Boon: The federal government invoked the Defense Production Act on recoverable critical minerals on July 30, 2026 — which is the sector Ferrox occupies. This puts SMTK in the middle of America’s accelerated pursuit of supply chain security.

Check Out SMTK While It’s Still Early…

Inline Image

Smartkem has assembled an interesting combination of developments over a relatively short period of time.

From its growing relationship with Ferrox Critical Minerals and repeat institutional financing to rapid revenue growth and exposure to expanding semiconductor and flexible electronics markets, the company continues to add new pieces to its story.

The Ferrox relationship also places Smartkem alongside a critical-minerals sector receiving increased attention as the U.S. strengthens domestic supply chains and supports materials considered important to advanced technology and national security.

At the same time, Smartkem’s 560% increase in TTM revenue and 61% gross margins indicate that its commercial activity is beginning to move beyond the earlier development stage.

The broader industry backdrop adds another layer. Organic semiconductors are projected to reach approximately $63.76B by 2030, while flexible electronics are forecast to approach $96.77B by 2033.

These expanding markets could support growing demand for materials designed to enable lighter, thinner, and more flexible electronic devices.

Add in a public float of approximately 19.43M shares and a backdrop shaped by recent critical-minerals policy developments, and it is easy to understand why SMTK has moved to the top of our watchlist.

Whether you are following advances in semiconductor materials, next-generation electronics, critical-minerals supply chains, or companies building commercial momentum alongside broader industry trends, Smartkem is certainly one to watch closely.

We have all eyes on SMTK this morning. Take a look at SMTK while it’s still early.

Sincerely,

Gary Silver
Managing Editor
Market Crux

MarketCrux.com (“MarketCrux” or “MC” ) is owned by Headline Media LLC, MC is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile MC brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors.

Pursuant to an agreement between Headline Media LLC and TD Media LLC, Headline Media LLC has been hired for a period beginning on 08/02/2026 and ending on 08/03/2026 to publicly disseminate information about (SMTK:US) via digital communications. Under this agreement, TD Media LLC has paid Headline Media LLC seven thousand five hundred USD (“Funds”). To date, including under the previously described agreement, Headline Media LLC has been paid fifteen thousand USD (“Funds”). These Funds were part of the twenty seven thousand five hundred USD funds that TD Media LLC received from a third party named LFG Equities Corp. who did receive the Funds directly or indirectly from the Issuer and does not own stock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices.

Neither Headline Media LLC, TD Media LLC and their member own shares of (SMTK:US).

Please see important disclosure information here: https://marketcrux.com/disclosure/smtk-ljuxr/#details

AbbVie Quietly Solved Its Biggest Problem—Now What?



AbbVie has moved beyond its Humira dependence, with diversified growth, a strong pipeline, and a reliable dividend supporting its next leg higher. Could the Apogee acquisition and sustained institutional backing propel ABBV toward $300?  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

 

 

Update your email preferences or unsubscribe here

345 N Reid Place #620
Sioux Falls, SD 57103, United States

If You Want to Buy AMD Stock, You’ll Statistically Do Better by Waiting



While there’s no guarantee about any outcome in the equities space, AM...  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
 

Update your email preferences or unsubscribe here

33 Southeast 4th Street
Boca Raton, FL 33432, United States

Share With Friends

Bookmark and Share
 
recipes for healthy food © 2008 | Créditos: Templates Novo Blogger